Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Rosiglitazone neuroprotective in mouse model of cerebral ischemia

May 17, 2006

Analgesic efficacy of Avinza detailed in clinical trials

May 17, 2006

Keppra approved by E.C. as adjunctive therapy for myoclonic seizures in patients with JME

May 16, 2006

Chimeric compound with antioxidant and calpain inhibitor activity improves MD symptoms

May 16, 2006

Barbeau Pharma prepares and tests novel dopamine D2 receptor antagonists

May 16, 2006

Gedeon Richter signs new agreement for antipsychotic RGH-188

May 16, 2006

Lexicon Genetics receives grant for target identification in spinal muscular atrophy

May 16, 2006

The alpha2delta1 subunit of the VGCC: a drug target for neuropathic pain / News in Context

May 16, 2006

Eugenol: a phytochemical with in vivo antihyperalgesic efficacy

May 16, 2006

Novel agents for treating neurological disorders disclosed in recent patent literature

May 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...